After failing to devise a way to replace the state's managed care organization tax, California lawmakers are facing a $1.1 billion hole in next year's health budget, Kaiser Health News reports.
While UnitedHealth Group's recently soured outlook on the Affordable Care Act exchanges left the industry reeling, predictions that it could spell the end of the healthcare reform law may be premature, according to one expert.
The past year has been full of changes that will affect physician practices for years to come. For insights into what will matter most to practices in 2016, we turned to Reid Blackwelder, M.D., immediate past president of the American Academy of Family Physicians. In an exclusive interview with FiercePracticeManagement, Blackwelder shared his thoughts on the impact of the shift to value-based care in general and the Medicare Access and CHIP Reauthorization Act in particular.
Predictions of widespread double-digit premium rate increases for consumers purchasing health insurance through the state marketplaces were overestimated, according to a report from the nonprofit Urban Institute.
Drug makers and insurance companies may finally be leaning toward some form of mutual understanding and compromise about rising prescription prices, according to STAT News.
Through its bundled payments pilot program, the Medicare program is currently testing models that it hopes will encourage higher-quality, lower-cost care and ultimately influence how other payers design their own alternative payment models, according to a policy brief from Health Affairs.
The expiration of a Medicare incentive program aimed at primary care physicians will hurt margins in some practices, according to an article in Kaiser Health News, though the overall effect on the Medicare market remains unclear.
Despite news that the nation's largest health insurer is struggling to make a profit on the Affordable Care Act exchanges, some conservative groups want to continue limiting the government's ability to cushion the companies' losses.
If physician executives and hospital leaders have not yet read all 1,358 pages of Medicare's 2016 Physician Fee Schedule Final Rule, there is one finding that is essential for them to understand, writes Kent Bottles, M.D., a lecturer at the Thomas Jefferson University School of Population Health and chief medical officer of PYA Analytics, in a post for Hospital Impact.
After examining the expenditures on the five highest-cost Medicare Part B drugs, a report by the Government Accountability Office found that high costs were concentrated among a small number of drugs and conditions.